1. 1EMEA. Guidance document: note for guidance on clinical investigation on medicinal products in the paediatric population (CPMP/ICH/2711/99), EMEA, London, 2001.
2. 2European Federation of Pharmaceutical Industry and Associations (EFPIA). Position paper “promotion of paediatric research in the European Union”, EFPIA, London, 2002.
3. Adverse drug reactions and off-label drug use in paediatric outpatients;Horen;Br. J. Clin. Pharmacol.,2002
4. Adverse drug reactions to unlicensed and off-label drugs on paediatric ward: a prospective study;Turner;Acta Paediatr.,1999
5. Pharmacokinetic studies in paediatric patients: clinical and ethical considerations;Kauffman;Clin. Pharmacokinet.,1992